Immune system scientists and computational biologists are developing a new tool to investigate how the body fights disease.

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

Newly discovered oncology drugs called “DNA-encoded tri-specific T-cell engagers,” or “DTriTEs,” engage the immune system ...

Scientists from the Garvan Institute of Medical Research have discovered that certain gene changes linked to leukemia may ...

What if your body’s own immune system could be taught to wipe out tumours — and do it so effectively that no further ...

Diagnosed with Stage 4 colon cancer, Ms Dimery underwent chemotherapy, radiation and other combination therapies -- none of ...

A Minnesota woman was told her stage 4 colon cancer couldn’t be cured. Two years later, she’s cancer-free — and says a last-chance clinical trial gave her back her life.

The new mechanism that on one hand enhances the efficacy of an anti-cancer drug, while also stopping the drug from attacking ...

May is Melanoma Awareness Month and Intermountain Health is unveiling an exciting new treatment program for Utahns with ...

Hone Health explains how inflammation-causing foods can wreak havoc on your body, and provides suggestions on what to eat ...

The celebration bell has announced birthdays, anniversaries, a marriage proposal, good results from various health scans and more.

SK Life Science Labs, a subsidiary of SK Biopharmaceuticals Co., Ltd., has announced a major advancement in oncology with the discovery of PVTX-405, a potent ...